YOUR BUSINESS AUTHORITY
Springfield, MO
The Food and Drug Administration has approved a new schizophrenia drug from Bristol Myers Squibb.
Called Cobenfy, the drug is the first novel type of treatment for the mental disorder in more than seven decades, according to CNBC.
Bristol Myers Squibb expects the twice-daily pill to become available in October.
Read more from CNBC.
Organizers hope to bolster client traffic to center city businesses.